Please assess the completion status of the following clinical trial:

Trial Title: Iron Aid IPS on Performance, Fatigue and Iron Levels During 12 Weeks of Supplementation and Aerobic Training

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. I am willing to and provide written and dated informed consent form to participate in the study;~2. I am female 18-30 years of age;~3. I am willing and able to comply with protocol;~4. My VO2 max is in compliance with age range (42 ml/kg/min);~5. I have not used or consumed any prescription drugs or supplements that could potentially confound the results of the current supplement;~6. I am apparently healthy and free from disease, as determined by a health history questionnaire;~7. I agree to abstain from strenuous activity and pre-workout supplementation 48 hours prior to each testing visit;~8. I must be fasted for 8 hours prior to each testing visit;~9. I agree to abstain from caffeine and alcohol consumption 24 hours prior to each testing visit;~10. I do not have any existing muscular disorders;~11. I am able to complete all testing on the 8th or 9th day after my menstrual cycle has ended.~Exclusion Criteria:~1. I use tobacco products or have quit within the past 6 months;~2. I am currently pregnant, plan on becoming pregnant, or become pregnant during the duration of the study;~3. I have given birth or been pregnant the past year;~4. I am currently taking or have taken any oral contraception within the past 6 months;~5. I have difficulty giving blood;~6. I am currently diagnosed with having or currently involved in a managed treatment plan for any known metabolic disorder including heart disease, arrhythmias, diabetes, gall bladder, thyroid disease, or hypogonadism;~7. I am diagnosed with having or are currently involved in a managed treatment plan for pulmonary disease, hypertension (defined as systolic blood pressure consistently greater than 140 mm Hg and/or a diastolic blood pressure greater than 90 mm Hg), hepatorenal disease, musculoskeletal disorders, neuromuscular/neurological diseases, autoimmune diseases, cancer, peptic ulcers, or anemia;~8. I am medically prescribed by a physician to take or regularly take over the counter medications for any heart, pulmonary, thyroid, anti-hyperlipidemic, hypoglycemic, anti-hypertensive, endocrinologic (e.g. thyroid, insulin, etc.), neuromuscular/neurological, or androgenic medications due to possible further health hazards that could occur with diet alteration or exercise training;~9. I report any unusual adverse events associated with this study that in consultation with the study investigators or supervision physician recommends removal from the study;~10. I have taken ergogenic levels of nutritional supplements that may affect muscle mass or aerobic capacity (e.g., creatine, HMB) or anabolic/catabolic hormone levels (e.g., androstenedione, DHEA, etc.) within 6 months prior to the start of the study;~11. I have consumed any iron or mineral type dietary supplements (excluding multivitamins) 1 month prior to the study;~12. I have a history of food or drug allergy of any kind;~13. I have any other condition in which principal investigator thinks may jeopardize the study or the subject.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 30 Years
- Healthy Volunteers: t

Study Arms:
- Sugar Pill (Type: PLACEBO_COMPARATOR): Maltodextrin (matches the weight of the active treatment) Taken once each day after breakfast, but before lunch.
- Iron Aid IPS (Iron Protein Succinylate) (Type: ACTIVE_COMPARATOR): IronAid Iron Protein Succinylate 30 mg Taken once each day after breakfast, but before lunch.

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues